Health Condition 1: null- upper limb fractures
Conditions
Interventions
Intervention1: supraclavicular brachial plexus block: supraclavicular block using 0.5% ropivacaine and 2% lignocaine
Control Intervention1: nalbuphine vesus dexmedetomidine as aduants t ropivacaine in
Sponsors
Sowmya Shanmugam
Eligibility
Inclusion criteria
Inclusion criteria: patient willing ASA 1 and 2 upper limb surgeries
Exclusion criteria
Exclusion criteria: patient not willing bleeding disorders infection at site of injection patients on anticoagulants patients with musculoskeletal disorders patients with history of allergy to local anaesthetics
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the anaesthetic efficacy of Nalbuphine and dexmedetomidine as an adjuvant to 0.5% ropivacaine and 2% lignocaine for supraclavicular block in upper limb surgeriesTimepoint: The time to request of the first analgesic will be noted to determine the Anaesthetic efficacy of the two adjuvants | — |
Secondary
| Measure | Time frame |
|---|---|
| time of onset of sensory and otor block duration of sensory and otor block level of sedation and side effets such as pruritis, bradycardia, respiratory dpressionTimepoint: the time to loss of pin prick sensation to demand of first analgesic is duration of sensory block time to loss of thumb movement to regain of thumb movement is duration of motor blocade | — |
Countries
India
Contacts
Public ContactR Uma
ESICMC PGIMSR, chennai
Outcome results
None listed